2Sano T,Sasako M,Yamamaoto S,et al. Gastric caner surgery:morbidty and mortality results from a prospective randomized controlled trial comparing D2and extended para -aortic lymphadenectomy [J]. J Clin Oncol, 2004,22 ( 14 ) : 2767-2773.
3Sung Kim,Do Hoon Lim,Jeeyun Lee,et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach[J]. Int J Radiat Oncol Biol Phys ,2005, 63 (5): P1279-1285.
4胡逸民.调强适形放射治疗[M].北京:中国协和医科大学出版社.2002,179-188.
5Cocconi G,Carlini P,Gamboni A,et al. Cisplatin,epirubicin,leucovorin and 5- fluorouracil (PELF) is more active than 5-fluorouracil,doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma [J]. Ann Oncol, 2003,14(8) : 1258-1263
6Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report : rationale and treatment implementation [J]. Int J Radiat Oncol Biol Phys,2002, 52 (2) :283-293.
7Macdonald JS , SmaUey SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocareinoma of the stomach or gastroesophageal junction [J], N Engl J Med, 2001,345(10) : 725-730.
